Characteristic | Frequency | Percent | |
---|---|---|---|
Warfarin indication | Prevention and treatment of deep vein thrombosis | 82 | 61.7 |
Pulmonary embolism | 13 | 9.8 | |
Atrial fibrillation ± Stroke | 28 | 21 | |
Myocardial infarction | 6 | 4.5 | |
Unspecified | 4 | 3.0 | |
Number of drugs per patient | <3 | 26 | 19.5 |
3-5 | 35 | 26.3 | |
6-8 | 40 | 30.1 | |
>8 | 32 | 24.1 | |
Mean | 6.0 | ||
Standard deviation | 3.3 | ||
Duration on warfarin therapy | < 1 month | 20 | 15.0 |
1-3 months | 56 | 42.1 | |
>3 months | 57 | 42.9 | |
Mean | 2.2 | ||
Standard deviation | 0.7 | ||
Warfarin dose^ | 2.5 mg | 25 | 18.8 |
5 mg | 78 | 58.6 | |
7.5 mg | 22 | 16.7 | |
10 mg | 5 | 3.8 | |
≥12.5 mg | 3 | 2.3 | |
No of interactions per patient | 0 | 1 | 0.8 |
1 | 31 | 23.2 | |
2-4 | 71 | 53.4 | |
≥5 | 30 | 22.6 | |
Total | 133 | 100 | |
Mean | 3.2 | ||
Standard deviation | 2.1 |